New Jersey Law360 provides breaking news and analysis on legal and regulatory issues in New Jersey. Coverage includes high-stakes litigation, policy developments, and corporate deals affecting the state.
The New Jersey Supreme Court has refused to second-guess a state appellate opinion issued this year that a now-defunct strip club owed money to state funds meant for employees who lose their jobs or become disabled because exotic dancers there were employees, not independent contractors.
A Pennsylvania man on Friday copped to his role in an insider trading conspiracy that profited from nonpublic tips about Celator Pharmaceuticals Inc.’s cancer drug and the company’s impending $1.5 billion sale, prosecutors said.
Mitsubishi Tanabe Pharma Corp. filed suit Friday in New Jersey federal court against India-based drugmaker Macleods Pharmaceuticals Ltd., alleging that the company had filed an abbreviated new drug application for a generic diabetes medication that would violate two of Mitsubishi’s patents.
New Jersey’s federal and state courts served as key legal battlegrounds in the health care, competition and consumer protection realms this year, and hosted white collar prosecutions that ended with a congressman’s mistrial and a lawyer facing prison time. Here’s a look at four notable cases that taught lawyers a thing or two in 2017.
Delaware on Thursday said that the U.S. Environmental Protection Agency's bid to nix a suit claiming it failed to act on petitions seeking to force it to curb pollution seeping across Delaware's border from power plants in neighboring states is merely another unlawful delay tactic.